Modelling HIV-1 control and remission
- PMID: 39117718
- PMCID: PMC11310323
- DOI: 10.1038/s41540-024-00407-8
Modelling HIV-1 control and remission
Abstract
Remarkable advances are being made in developing interventions for eliciting long-term remission of HIV-1 infection. The success of these interventions will obviate the need for lifelong antiretroviral therapy, the current standard-of-care, and benefit the millions living today with HIV-1. Mathematical modelling has made significant contributions to these efforts. It has helped elucidate the possible mechanistic origins of natural and post-treatment control, deduced potential pathways of the loss of such control, quantified the effects of interventions, and developed frameworks for their rational optimization. Yet, several important questions remain, posing challenges to the translation of these promising interventions. Here, we survey the recent advances in the mathematical modelling of HIV-1 control and remission, highlight their contributions, and discuss potential avenues for future developments.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures




Similar articles
-
Advances in the mathematical modeling of posttreatment control of HIV-1.Curr Opin HIV AIDS. 2025 Jan 1;20(1):92-98. doi: 10.1097/COH.0000000000000896. Epub 2024 Nov 7. Curr Opin HIV AIDS. 2025. PMID: 39633541 Review.
-
Modeling HIV persistence and cure studies.Curr Opin HIV AIDS. 2018 Sep;13(5):428-434. doi: 10.1097/COH.0000000000000490. Curr Opin HIV AIDS. 2018. PMID: 29916846 Free PMC article. Review.
-
HIV Proviral Burden, Genetic Diversity, and Dynamics in Viremic Controllers Who Subsequently Initiated Suppressive Antiretroviral Therapy.mBio. 2021 Dec 21;12(6):e0249021. doi: 10.1128/mBio.02490-21. Epub 2021 Nov 16. mBio. 2021. PMID: 34781741 Free PMC article.
-
A mechanistic theory to explain the efficacy of antiretroviral therapy.Nat Rev Microbiol. 2014 Nov;12(11):772-80. doi: 10.1038/nrmicro3351. Epub 2014 Sep 29. Nat Rev Microbiol. 2014. PMID: 25263222 Review.
-
A Review of Current Strategies Towards the Elimination of Latent HIV-1 and Subsequent HIV-1 Cure.Curr HIV Res. 2021;19(1):14-26. doi: 10.2174/1570162X18999200819172009. Curr HIV Res. 2021. PMID: 32819259 Free PMC article.
Cited by
-
Trade-off between the antiviral and vaccinal effects of antibody therapy in the humoral response to HIV.J R Soc Interface. 2024 Dec;21(221):20240535. doi: 10.1098/rsif.2024.0535. Epub 2024 Dec 4. J R Soc Interface. 2024. PMID: 39626747
-
A consensus mathematical model of vaccine-induced antibody dynamics for multiple vaccine platforms and pathogens.Front Immunol. 2025 Jun 26;16:1596518. doi: 10.3389/fimmu.2025.1596518. eCollection 2025. Front Immunol. 2025. PMID: 40642065 Free PMC article.
-
Mathematical modeling and mechanisms of HIV latency for personalized anti latency therapies.NPJ Syst Biol Appl. 2025 Jun 12;11(1):64. doi: 10.1038/s41540-025-00538-6. NPJ Syst Biol Appl. 2025. PMID: 40506472 Free PMC article. Review.
-
Antiviral capacity of the early CD8 T-cell response is predictive of natural control of SIV infection: Learning in vivo dynamics using ex vivo data.PLoS Comput Biol. 2024 Sep 10;20(9):e1012434. doi: 10.1371/journal.pcbi.1012434. eCollection 2024 Sep. PLoS Comput Biol. 2024. PMID: 39255323 Free PMC article.
-
Mechanism for evolution of diverse autologous antibodies upon broadly neutralizing antibody therapy of people with HIV.bioRxiv [Preprint]. 2025 Mar 10:2025.03.05.641732. doi: 10.1101/2025.03.05.641732. bioRxiv. 2025. PMID: 40161612 Free PMC article. Preprint.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical